Acutus medical announces ceo appointment and preliminary second quarter revenue results

Carlsbad, calif., july 21, 2022 (globe newswire) -- acutus medical, inc. (“acutus” or the “company”) (nasdaq: afib), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced that david roman has been appointed president and chief executive officer, and member of the board of directors, effective immediately. the company also announced preliminary second quarter revenue results.
AFIB Ratings Summary
AFIB Quant Ranking